Med spa FAQ

Semaglutide is a GLP-1 receptor agonist that helps regulate appetite and blood sugar.

It is commonly prescribed for:

• Medical weight loss
• Type 2 diabetes management
• Appetite regulation

Semaglutide works by slowing stomach emptying and increasing satiety signals in the brain, which helps reduce hunger and calorie intake.

Tirzepatide is a dual-action medication that activates both:

• GLP-1 receptors
• GIP receptors

This dual pathway can enhance metabolic regulation and appetite suppression, making tirzepatide one of the most powerful medical weight loss treatments currently available.

GLP-1 medications support weight loss by:

• Reducing appetite
• Increasing fullness
• Slowing gastric emptying
• Improving blood sugar control
• Supporting insulin sensitivity

These effects make it easier for patients to maintain a calorie deficit while following a structured weight management plan.

Weight loss results vary by individual, but clinical studies show that patients using GLP-1 medications under medical supervision may lose 10–20% of their body weight over time.

Long-term success depends on factors including:

• Nutrition habits
• Muscle preservation
• Physical activity
• Metabolic health
• Maintenance planning

This is why structured programs are important for sustainable outcomes.

GLP-1 medications can reduce appetite, but they are most effective when combined with:

• Structured nutrition
• Resistance training
• Muscle preservation strategies
• Ongoing clinical oversight

Medication alone is rarely a complete solution for long-term metabolic health.

When medication stops:

• Hunger signals may increase
• Metabolic rate may decline
• Appetite may return

Without a structured maintenance strategy, the body often attempts to restore previous weight.

A medical weight loss program is a physician-guided approach to weight management that may include:

• Medical evaluation
• Prescription medications
• Nutrition planning
• Metabolic monitoring
• Lifestyle guidance

The goal is to create a safe and effective treatment plan tailored to each patient.

A telehealth weight loss clinic allows patients to receive medical weight loss treatment remotely.

Through secure telemedicine platforms, patients can:

• Consult with licensed providers
• Receive personalized treatment plans
• Access GLP-1 medications when appropriate
• Receive ongoing monitoring and support

Medication is typically shipped directly to the patient’s home.

GLP-1 medications are FDA-approved and widely studied.

When prescribed by qualified medical providers, they are considered safe for many patients. However, individual medical history must be evaluated before starting treatment.

Patients may qualify if they:

• Have a BMI over 27 with health conditions
• Have a BMI over 30
• Have struggled with traditional dieting
• Want medically supervised weight management

A provider must review your health history to determine eligibility.

Treatment length varies depending on the patient.

Some individuals use medication for several months during the weight loss phase, while others continue longer as part of a metabolic management plan.

A gradual transition plan is often recommended.

Possible side effects may include:

• Nausea
• Mild digestive discomfort
• Decreased appetite
• Fatigue during adjustment

Most side effects improve as the body adapts.

Many patients begin noticing appetite changes within the first few weeks of treatment.

Weight loss typically becomes more noticeable within the first 8–12 weeks.

Yes.

GLP-1 medications help improve insulin sensitivity and blood sugar regulation, which can benefit patients with metabolic syndrome or insulin resistance.

Indirectly, yes.

While GLP-1 medications primarily reduce appetite, long-term metabolic health depends on preserving muscle mass and maintaining metabolic rate.

Muscle tissue plays a key role in metabolic health.

Losing muscle during weight loss can reduce resting metabolic rate, making it easier to regain weight.

Structured programs prioritize:

• Protein intake
• Resistance training
• Metabolic preservation

Metabolic weight loss focuses on improving the underlying biological systems that regulate body weight.

This includes:

• Hormones
• Insulin signaling
• Energy expenditure
• Appetite regulation

The goal is sustainable weight management rather than temporary dieting.

Sustainable programs include:

• Medical oversight
• Long-term planning
• Lifestyle integration
• Maintenance strategies

Programs focused only on rapid weight loss often fail to produce lasting outcomes.

Most weight regain happens after the initial weight loss phase.

Maintenance planning may include:

• Medication tapering
• Metabolic monitoring
• Nutritional stabilization
• Lifestyle structure

This helps protect long-term results.

GLP-1 medications may reduce cravings and appetite signals, which can indirectly help patients who struggle with emotional eating.

However, behavioral and psychological factors must also be addressed.

In certain cases, compounded formulations may be available through licensed pharmacies.

Patients should only obtain medications through legitimate medical providers and compliant pharmacies.

The first step is a medical consultation.

During this appointment, providers review:

• Medical history
• Weight management goals
• Metabolic factors
• Medication eligibility

Many clinics focus primarily on medication.

At Auréa Finezza | Med Lounge, we focus on metabolic stability and long-term outcomes.

Our model includes:

• Physician-guided care
• Structured metabolic planning
• Muscle preservation strategy
• Maintenance framework

Medication is a tool within a broader strategy.

Patients begin with a Metabolic Strategy Session, where we review:

• Medical history
• Previous weight loss experiences
• Metabolic goals
• Treatment options

From there, a personalized metabolic care plan is developed.